Table 1

Summary of patients with R69W MCP mutations

PatientDiseaseSexAge of onset, yRelapses, no.Renal sequelae, no.InheritanceComplement protein testedOther mutationsSource
aHUS NA NA NA Het NA Het N151S CFI, hom MCPggaac risk haplotype Esparza-Gordillo et al, Rodríguez de Córdoba, written communication, December 2006 
aHUS NA NA NA Het NA Het c.905–925del21n MCP, het N151S CFI, het MCPggaac risk haplotype Rodríguez de Córdoba, written communication, December 2006 
aHUS Childhood None Hom C3, FB, FH, FI, MCP None V.F.B., December 2006 
aHUS None Het C3, FB, FH, FI, MCP Het P32A CFI V.F.B., December 2006 
PatientDiseaseSexAge of onset, yRelapses, no.Renal sequelae, no.InheritanceComplement protein testedOther mutationsSource
aHUS NA NA NA Het NA Het N151S CFI, hom MCPggaac risk haplotype Esparza-Gordillo et al, Rodríguez de Córdoba, written communication, December 2006 
aHUS NA NA NA Het NA Het c.905–925del21n MCP, het N151S CFI, het MCPggaac risk haplotype Rodríguez de Córdoba, written communication, December 2006 
aHUS Childhood None Hom C3, FB, FH, FI, MCP None V.F.B., December 2006 
aHUS None Het C3, FB, FH, FI, MCP Het P32A CFI V.F.B., December 2006 

NA indicates not available; Het, heterozygous; and Hom, homozygous.

*Patients 1 and 2 and patients 3 and 4 are father and daughter, respectively.

Components listed were measured and were normal; MCP was measured by FACS.

or Create an Account

Close Modal
Close Modal